Table 2.
Percent of Patients with Scleritis and Systemic Condition
| Condition | N | Scleritis cases | % of scleritis cases | % of disease with scleritis |
|---|---|---|---|---|
| Total | 5,917,914 | 2702 | 31.4% | 0.05% |
| RA | 19,923 | 184 | 6.8% | 0.9% |
| HLA-B27 | 26,680 | 153 | 5.7% | 0.6% |
| Sjogren | 10,576 | 121 | 4.5% | 1.1% |
| Gout | 47,712 | 95 | 3.5% | 0.2% |
| Lupus | 11,696 | 80 | 3.0% | 0.7% |
| GPA | 859 | 45 | 1.7% | 5.2% |
| Sarcoid | 7699 | 40 | 1.5% | 0.5% |
| MS | 9980 | 30 | 1.1% | 0.3% |
| PMR/GCA | 4456 | 29 | 1.1% | 0.7% |
| MCTD | 4061 | 27 | 1.0% | 0.7% |
| Scleroderma | 4232 | 17 | 0.6% | 0.6% |
| PAN | 365 | 11 | 0.4% | 3.0% |
| Behcet | 317 | 7 | 0.3% | 2.2% |
| JIA/JRA | 1351 (23 HLA-B27+) | 9 (0 HLA-B27+) | 0.3% | 0.7% |
RA Rheumatoid arthritis, GPA Granulomatosis with polyangiitis, MS Multiple sclerosis, MCTD Mixed connective tissue disorder, PAN Polyarteritis nodosa, PMR/GCA Polymyalgia rheumatica & giant cell arteritis, JIA/JRA Juvenile inflammatory arthritis / juvenile rheumatoid arthritis